Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs

Pancreatic cancer is one major digestive malignancy with a poor prognosis. Given the clinical importance of lncRNAs, developing a novel molecular panel with lncRNAs for pancreatic cancer has great potential. As a result, an 8-lncRNA-based robust prognostic signature was constructed using a random su...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Di, Yang, Yuchen, Cai, Qiang, Ye, Feng, Deng, Xiaxing, Shen, Baiyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Genetics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515791/
https://www.ncbi.nlm.nih.gov/pubmed/36186449
http://dx.doi.org/10.3389/fgene.2022.973444

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9515791/
https://www.ncbi.nlm.nih.gov/pubmed/36186449
http://dx.doi.org/10.3389/fgene.2022.973444

Ejemplares similares